Camurus UK & Ireland News and Activities

Camurus UK & Ireland is owned by Camurus.

Camurus is a company listed under the stock ticker CAMX (SE).

Camurus has a direct presence in 2 countries.

View the org chart displaying its 2 main executives

Most searched biographies at Camurus UK & Ireland

• Samantha Nickerson, General Manager
• Richard Jameson, Chief Commercial Officer

Popular executive movements at Camurus

• Jane Buus Laursen will join the company as Chief Corporate Development Officer on Apr. 23, 2026  (posted on February 23 2026).

Create your alert
to follow the executive moves at Camurus UK & Ireland.

Camurus has 2,403 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• GNI has announced the acquisition of Ayumi Pharmaceutical  (posted on June 12 2026).
• Humacyte has just announced a $50 Million fundraising (posted on June 12 2026).
• Beren Therapeutics has just announced a $300 Million fundraising (posted on June 12 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Camurus UK & Ireland

Social media about Camurus UK & Ireland

• Camurus UK & Ireland on Wikipedia, Google News & Yahoo Finance
• Camurus UK & Ireland on LinkedIn, X (Twitter) & YouTube